Bionema

The company's business model is centered on creating, manufacturing, and selling biocontrol agents—naturally occurring microorganisms like fungi, bacteria, and nematodes—that target specific insect pests. This approach serves clients in the horticulture, agriculture, turf and amenity, forestry, and public health sectors. Revenue is generated through the sale of its extensive product portfolio, which includes over 70 biopesticides, biostimulants, and biofertilizers, as well as through licensing and technology transfer agreements with major agrochemical companies. A notable milestone was the acquisition of two of its bioinsecticide technologies, NemaTrident® and UniSpore®, by Syngenta Crop Protection in 2022. The company also provides research and development, product testing, and training services to support the adoption of biological pest control.

Bionema has developed a range of products that offer an alternative to conventional chemical pesticides. A key product was NemaTrident®, a patented, tri-component solution utilizing nematodes for insect control, which was recognized with the King's Award for Enterprise in the Innovation category in 2024. Following the sale of this technology, Bionema launched NemaGen™, a range of beneficial nematodes designed for improved adaptability to local ecosystems. The company is also developing ten other products, including bioinsecticides, biofungicides, and bionematicides, using proprietary microencapsulation and water-dispersible granule (WDG) formulations. These delivery technologies are designed to enhance the efficacy of biological agents by 20-40% compared to traditional products, offering better stability and targeted delivery. Bionema has secured significant funding, including over $1 million in grants and multiple seed rounds from investors like the Development Bank of Wales and Swansea University, to advance its research and commercialization efforts.